Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren't Crazy About It But Hedge Funds Love It
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Synageva Biopharma Corp (GEVA)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Arena Pharmaceuticals, Inc. (ARNA): What Do The Smartest Investors Think?
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Alnylam Pharmaceuticals, Inc. (ALNY): Here's What The Smart Money Thinks
To the average investor, there are tons of metrics investors can use to watch stocks. Two of the most innovative are hedge fund and insider trading sentiment.
Synageva BioPharma Corp (GEVA): Hedge Funds and Insiders Are Bullish, What Should You Do?
In the 21st century investor’s toolkit, there are tons of indicators investors can use to track stocks. Some of the most useful are hedge fund and insider trading activity.
Arena Pharmaceuticals, Inc. (ARNA): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Infinity Pharmaceuticals Inc. (INFI), Oncothyreon Inc (USA) (ONTY), Synageva BioPharma Corp (GEVA): Three Horrendous Healthcare Stocks This Week
There's one drawback to having the stock market indexes hit record highs yet again: It makes finding truly horrendous health-care stocks for our weekly series much more challenging.
Arena Pharmaceuticals, Inc. (ARNA): The Mind-Blowing Data You Missed
At the moment, there are dozens of gauges shareholders can use to track stocks. Some of the most useful are hedge fund and insider trading movement.
Do Hedge Funds and Insiders Love Synageva BioPharma Corp (GEVA)?
At the moment, there are dozens of metrics shareholders can use to watch publicly traded companies. A couple of the most useful are hedge fund and insider trading activity.
Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of the fourth quarter of 2012.
Pharmacyclics, Inc. (PCYC), Genomic Health, Inc. (GHDX)...Mega-Hedge Fund Focusing on The Life Sciences
The $3+ billion Baker Brothers Advisors equity portfolio, managed by brothers Julian and Felix Baker, focuses almost exclusively on life science companies with a small to medium sized market capitalization...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
